| Volume: | 529,105 |
|---|---|
| Day's Low: | $22.45 |
| 52-wk Low: | $15.75 |
| Previous Close: | $22.75 |
| Dividend: | $0.00 |
| Market Cap: | 2,667,600 |
| Avg Volume: | 1,421,400 |
|---|---|
| Day's High: | $22.88 |
| 52-wk High: | $26.14 |
| Open Price: | $22.82 |
| Yield: | 0.00% |
| P/E (Forward): | 8.39 |
| 8:04 PM | 11/16/2009 | UPDATE: Icahn Reports New Stakes In Genzyme, Forest Labs |
| 7:03 PM | 11/16/2009 | Icahn Reports New Stakes In Genzyme, Forest Labs At Sept 30 |
| 11/23/2009 | Which Drug Companies Could Be Private-Equity Targets? |
| 10/24/2009 | 13D Filings |
| 10/2/2009 | New Beginnings for Endo Pharma |
| 7/31/2009 | Drug stocks slip; Genzyme slides on FDA woes |
| 7/1/2009 | Panel: Down With Vicodin & Percocet. Long Live NyQuil! |
| 7/1/2009 | U.S. panel recommends painkiller restrictions |
| 1/6/2009 | Tuesday's biggest gaining and declining stocks |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.63 | 0.61 | 3.28 |
| EPS, GAAP | 0.42 | 0.57 | -26.32 |
| Consensus Estimate | 0.64 | 0.52 | 23.08 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.69 | 2.34 | 14.96 |
| EPS, GAAP | 1.65 | 1.87 | -11.76 |
| Consensus Estimate | 2.50 | NA | NA |
| ENDP | Industry Average | |
| P/E (TTM) | 13.79 | 82.10 |
| P/E (Forward) | 8.39 | 1.20 |
| PEG Ratio | 0.82 | 0.08 |
| Price/Sales | 1.89 | 3.90 |
| Beta | 0.48 | 0.48 |